Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Case Study
Re-tooling anti-microbial research for the 21st century
Antimicrobial resistance (AMR) is one of today’s major global public health challenges. Recently, there has been renewed investment in the discovery of novel antimicrobials to urgently address the growing number of drug-resistant infections. This case study describes how Professor Gordon Dougan and his team at the Cambridge Biomedical Research Centre are using high-content analysis to phenotype individual bacteria within a population to investigate adaptive mechanisms of antimicrobial resistance, and to screen for novel alternatives to existing antimicrobials.
For research use only. Not for use in diagnostic procedures.
To view the full content please answer a few questions
Download Resource
Re-tooling anti-microbial research for the 21st century